NOV 08, 2018 9:00 AM PST

Influenza 2018-2019: Are you ready?

Sponsored by: DiaSorin Molecular LLC
Speaker

Abstract

DATE: November 8, 2018
TIME:  9:00AM PST

Annual epidemics of influenza place a substantial burden on the health of people in the United States. CDC estimates that influenza has resulted in between 9.2 million and 35.6 million illnesses, between 140,000 and 710,000 hospitalizations, and between 12,000 and 56,000 deaths annually since 2010.

The cornerstone of influenza prevention is routine annual influenza vaccination, which is recommended for all persons aged ≥6 months who do not have contraindications. Multiple different vaccine types are available, including inactivated, live attenuated, and recombinant vaccines, as well as high dose and adjuvanted inactivated versions.

The majority of currently circulating influenza viruses are susceptible to the neuraminidase inhibitor antiviral medications—oseltamivir, zanamivir and peramivir. Antiviral treatment with a neuraminidase inhibitor is recommended as early as possible for patients with confirmed or suspected influenza who have severe, complicated, or progressive illness; who require hospitalization; or who are at increased risk for influenza-related complications.

Appropriate treatment of patients with influenza depends on accurate and timely diagnosis, and early diagnosis can reduce the inappropriate use of antibiotics and provide the option of using antiviral therapy. Diagnostic tests available for influenza include viral culture, serology, rapid antigen testing, reverse transcription PCR, immunofluorescence assays, and rapid molecular assays. Molecular assays are increasingly becoming the diagnostic tests of choice.

 

Learning Objectives:

  • Describe the epidemiology and clinical impact of seasonal influenza
  • Understand strategies for prevention of influenza including current vaccine recommendations
  • Recognize the value of diagnostic testing including advantages and disadvantages of different assay types

Show Resources
NOV 08, 2018 9:00 AM PST

Influenza 2018-2019: Are you ready?

Sponsored by: DiaSorin Molecular LLC

Specialty

Laboratory Testing

Microbiology

Molecular Biology

Infectious Disease

Molecular Diagnostics

Clinical Diagnostics

Immunology

Diagnostics

Clinical Research

Genetics

Clinical Chemistry

Cancer Research

Medicine

Biotechnology

Cell Biology

Geography

North America77%

Asia9%

Europe8%

Africa3%

South America2%

Registration Source

Website Visitors61%

Email Promotions25%

WAVE Newsletter Promotion11%

Social Media Promotions1%

Client/Sponsor Promotions1%

Other1%

Job Title

Medical Laboratory Technician20%

Student15%

Facility/Department Manager12%

Clinical Laboratory Scientist12%

Lab Management8%

Research Scientist7%

Executive6%

Medical Doctor/Specialist5%

Educator/Faculty5%

Scientist4%

QC/QA3%

Microbiologist2%

Post Doc2%

Marketing/Sales1%

Organization

Hospital25%

Clinical Laboratory17%

Academic Institution11%

Biotech Company6%

Government6%

Research Institute5%

Medical Center4%

Medical Device Company4%

Medical School3%

Non-Profit Organization2%

Life Science Company2%

Pharmaceutical Company1%

Ambulatory Care1%

Government/public1%

Other4%


Show Resources
Show Resources
Resources
Connect with us